Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media
- PMID: 20538297
- DOI: 10.1016/j.jss.2010.03.044
Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media
Abstract
Background: Compared with rare CD4+CD25+ regulatory T cells (Tregs), CD4+CD25- T cells are abundant in peripheral blood. Studies have demonstrated that tumors can convert naive CD4+CD25- T cells into CD4+CD25+Foxp3+ Tregs; however, the potential application of the converted Tregs in transplant medicine has not well demonstrated.
Materials and methods: CD4+CD25- T cells isolated cultured for 5 d in various combinations of cell culture medium and conditioned medium from RenCa cells. Foxp3 levels were determined by flow cytometry and real-time polymerase chain reaction. BALB/c mouse mononuclear cells (responder) combined with different ratios of the converted CD4+CD25+ Tregs were co-cultured with inactivated C57BL/6 mononuclear cells (stimulator) in one-way mixed lymphocyte reaction (MLR). In addition, the converted Tregs were transferred into a mouse skin transplant model, and graft histology, survival time, and delayed-type hypersensitivity were assessed.
Results: CD4+CD25- T cells cultured in media supplemented with increasing concentrations of RenCa conditioned medium were partially converted into CD4+CD25+ Tregs; conversion increased as the percentage of conditioned medium increased. Moreover, the converted CD4+CD25+ Tregs possessed characteristics similar to those of naturally occurring Tregs, including Foxp3 expression and the ability to suppress T cell proliferation in one-way MLR in a concentration-dependent manner. Immunosuppressive effects of the converted CD4+CD25+ Tregs were also similar to those of naturally occurring Tregs in vivo, suppressing allograft rejection and prolonging survival time of allogeneic skin grafts following adoptive transfer in mice (P<0.05).
Conclusion: Our findings indicate that CD4+CD25- T cells cultured with conditioned media from tumor cells may be useful for obtaining sufficient numbers of Tregs, which may help suppress acute rejection and prolong graft survival.
Crown Copyright © 2011. Published by Elsevier Inc. All rights reserved.
Similar articles
-
CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.Chin Med J (Engl). 2010 Apr 5;123(7):942-8. Chin Med J (Engl). 2010. PMID: 20497692
-
Injection of donor-derived OX62+ splenic dendritic cells with anti-CD4 monoclonal antibody generates CD4+CD25+FOXP3+ regulatory T cells that prolong allograft skin survival indefinitely and abrogate production of donor-specific antibodies in a rat model.Transplant Proc. 2009 Oct;41(8):3363-6. doi: 10.1016/j.transproceed.2009.08.038. Transplant Proc. 2009. PMID: 19857750
-
Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.Transpl Immunol. 2008 May;19(2):127-35. doi: 10.1016/j.trim.2008.02.003. Epub 2008 Mar 20. Transpl Immunol. 2008. PMID: 18503888
-
Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.Immunol Rev. 2006 Aug;212:314-29. doi: 10.1111/j.0105-2896.2006.00422.x. Immunol Rev. 2006. PMID: 16903923 Review.
-
Alloantigen specific T regulatory cells in transplant tolerance.Int Immunopharmacol. 2009 May;9(5):570-4. doi: 10.1016/j.intimp.2009.01.016. Epub 2009 Jan 29. Int Immunopharmacol. 2009. PMID: 19539571 Review.
Cited by
-
Colorectal Cancer and Immunity: From the Wet Lab to Individuals.Cancers (Basel). 2021 Apr 4;13(7):1713. doi: 10.3390/cancers13071713. Cancers (Basel). 2021. PMID: 33916641 Free PMC article. Review.
-
Immunosuppressive effect of renal cell carcinoma on phenotype and function of dendritic cells.Int Urol Nephrol. 2014 May;46(5):915-20. doi: 10.1007/s11255-013-0595-8. Epub 2013 Nov 8. Int Urol Nephrol. 2014. PMID: 24202958
-
Alloreactive Regulatory T Cells Allow the Generation of Mixed Chimerism and Transplant Tolerance.Front Immunol. 2015 Nov 23;6:596. doi: 10.3389/fimmu.2015.00596. eCollection 2015. Front Immunol. 2015. PMID: 26635810 Free PMC article.
-
Anti-tumor effect of ribavirin in combination with interferon-α on renal cell carcinoma cell lines in vitro.Cancer Cell Int. 2014 Sep 3;14:63. doi: 10.1186/1475-2867-14-63. eCollection 2014. Cancer Cell Int. 2014. PMID: 25904822 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials